Clinical Trials Directory

Trials / Conditions / Skin and Subcutaneous Tissue Bacterial Infections

Skin and Subcutaneous Tissue Bacterial Infections

10 registered clinical trials studyying Skin and Subcutaneous Tissue Bacterial Infections.

StatusTrialSponsorPhase
CompletedTNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection
NCT03964493
TenNor Therapeutics LimitedPhase 2
CompletedStaph Household Intervention for Eradication (SHINE)
NCT02572791
Washington University School of MedicinePhase 4
CompletedStudy of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections
NCT02796716
Denver Health and Hospital Authority—
CompletedDelafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infectio
NCT01984684
Melinta Therapeutics, Inc.Phase 3
CompletedStudy of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infec
NCT02060513
Connie Price—
CompletedDelafloxacin Versus Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infe
NCT01811732
Melinta Therapeutics, Inc.Phase 3
CompletedA Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Ski
NCT01519492
Affinium Pharmaceuticals, LtdPhase 2
CompletedTR-701 FA vs Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
NCT01421511
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Phase 3
CompletedA Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
NCT01283581
Melinta Therapeutics, Inc.Phase 2
CompletedTR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
NCT01170221
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Phase 3